| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophys J, July 2002, p. 484-490, Vol. 83, No. 1
*Orion Pharma, Cardiovascular Research, FIN-02101 Espoo, Finland;
and
Department of Physical Sciences, University of
Helsinki, FIN-00014 Helsinki, Finland
| |
ABSTRACT |
|---|
|
|
|---|
The structure of a 36-amino-acid-long N-terminal fragment
of human phospholamban phosphorylated at Ser-16 and Thr-17 and
Cys-36
Ser mutated was determined from nuclear magnetic resonance
data in aqueous solution containing 30% trifluoroethanol. The peptide assumes a conformation characterized by two
-helices connected by an
irregular strand, which comprises the amino acids from Arg-13 to
Pro-21. The proline is in a trans conformation. The two
phosphate groups on Ser-16 and Thr-17 are shown to interact preferably
with the side chains of Arg-14 and Arg-13, respectively. The helix comprising amino acids 22 to 35 is well determined (the rmsd for the backbone atoms, calculated for a family of 24 nuclear magnetic resonance structures is 0.69 ± 0.28 Å). The structures of
phosphorylated and unphosphorylated phospholamban are compared, and the
effect of the two phosphate groups on the relative spatial position of the two helices is examined. The packing parameters
(interhelical angle) and d (minimal interhelical distance) are
calculated: in the case of the phosphorylated phospholamban,
= 100 ± 35° and d = 7.9 ± 4.6 Å,
whereas for the unphosphorylated peptide the values are
= 80 ± 20° and d = 7.0 ± 4.0 Å. We
conclude that 1) the phosphorylation does not affect the structure of
the C terminus between residues 21 and 36 and 2) the phosphorylated phospholamban has more loose helical packing than the nonphosphorylated.
| |
INTRODUCTION |
|---|
|
|
|---|
Phospholamban (PLB) is a small protein (52 amino
acids) that regulates the affinity of the cardiac sarcoplasmic
reticulum Ca2+-ATPase (SERCA2a) for calcium. The
role of PLB in the regulation of the cardiac contraction has been
defined by gene transfer (Kadambi et al., 1996
) and knockout (Luo et
al., 1994
) technology in the mouse. PLB is present not only in cardiac
myocytes but also in slow-twitch and smooth muscle. Recently, evidence
was given that PLB is expressed also in aorta endothelial cells (Paul,
1998
) in which it could play a role in the tissue relaxation (Sutliff et al., 1999
).
PLB can be phosphorylated by both cAMP- (Karczewski et al., 1987
)
and Ca2+/calmodulin-dependent phosphokinases
(Iwasa et al., 1985
). The phosphorylation/dephosphorylation of
phospholamban removes and restores, respectively, its inhibitory
activity on SERCA2a (Jackson and Colyer, 1996
; Tada and Kadoma, 1989
).
It has been in fact shown that phospholamban, in its nonphosphorylated
form, binds to SERCA2a and inhibits this pump by lowering its affinity
for Ca2+, whereas the phosphorylated form does
not exert the inhibition (Toyofuku et al., 1993
). PLB is phosphorylated
at two sites, namely at Ser-16 for a cAMP-dependent phosphokinase and
at Thr-17 for a Ca2+/calmodulin-dependent
phosphokinase. It was recently demonstrated that the phosphorylation at
Ser-16 is a prerequisite for the phosphorylation at Thr-17 (Luo et al.,
1998
). Previous studies on a shorter fragment of PLB (1-20 amino
acids) indicated that the phosphorylation leads to a local perturbation
in the secondary structure (Mortishire-Smith et al., 1995
) and to a
weakened interaction with SERCA (Levine et al., 1999
). Evidence was
given for a specific interaction between Ser-16P and Arg-14 in a short
PLB fragment (9-20 amino acids) (Quirk et al., 1996
), whereas other
authors, from MD simulation data, proposed that the guanidinium
groups of both Arg-13 and Arg-14 have the potential to interact with
the phosphoryl group of Ser-16P (Mortishire-Smith et al., 1995
, 1998
).
Recently, the structure of a 36-amino-acid-long N-terminal fragment of
PLB (PLB36) in aqueous solution containing 30% trifluoroethanol (TFE)
was determined by nuclear magnetic resonance (NMR) (Pollesello et al.,
1999
), and PLB was shown to assume a conformation in which two
-helices are connected by a less structured turn centered at
residues Glu-19-Pro-21 (near the PLB phosphorylation sites). In the
present study the structure of the 36-residue N-terminal fragment of
PLB phosphorylated at both Ser-16 and Thr-17 is determined. The
structures obtained for the phosphorylated and unphosphorylated PLB1-36 under the same experimental conditions are compared, and the
effect of the phosphorylation is discussed.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Synthesis of the doubly phosphorylated phospholamban fragment
The 36-amino acid PLB peptide phosphorylated at Ser-16 and
Thr-17 and with a mutation at the carboxy terminus (Cys-36
Ser) was
synthesized at MedProbe AS (Norway). The Cys-36
Ser mutation at the C
terminus was introduced to prevent dimerization, rather then using
DTTd10, otherwise required for the
protection of the Cys SH group. The peptide was purified by
reverse phase high-pressure liquid chromatography using a C-18, 5 µm,
250 × 4.6-mm column. A linear gradient of acetonitrile and
0.075% trifluoroacetic acid (TFA) (20%-50% in 30 min) in 0.1% TFA
was used for elution. The purified peptide was further characterized by
MALDI-TOF mass spectrometry in reflector mode with a BIFLEX mass
spectrometer using a 337-nm nitrogen laser for the ionization of the
sample. The sample was applied in a solution containing 30%
acetonitrile/0.1% TFA together with a droplet of sinapinic acid matrix
for mass spectrometry analysis. The total amount of purified
peptide was 10 mg, and the purity of the peptide was 96% according to
mass spectrometry and high-pressure liquid chromatography.
NMR spectra
1H- and 31P-NMR
spectra were acquired at 600 and 242 MHz, respectively, on a Varian
UNITY600 NMR spectrometer. One-dimensional and two-dimensional NMR
spectra were obtained for a 3-mM solution of the 36-amino acids
fragment of phospholamban phosphorylated on Ser-16 and Thr-17 (C36S
mutated) in the solvent mixture
H2O/D2O/d3-TFE (perdeuterated trifluoroethanol) (63:7:30). The pH was adjusted to
3.05 ± 0.05 (uncorrected for deuterium isotope effects) with microliter amounts of NaOD. Correlation spectroscopy (COSY), total correlation spectroscopy (30-90 ms), and nuclear Overhauser-effect spectroscopy (NOESY) (40-200 ms) spectra were recorded at 17°C and
27°C by the States-time proportional phase incrementation method (Marion et al., 1989
), using a spectral width of 8.5 ppm. The
two-dimensional data were weighted and Fourier transformed to 2 k × 1 k real point matrices. The transmitter presaturated (2.0 s)
residual solvent line was reduced by deconvolution, and NOESY data was
taken with the Watergate sequence (Piotto et al., 1992
). The spectra
were referenced to the residual solvent signal (4.75 ppm at 27°C,
0.01 ppm/°C). A series of 10 one-dimensional spectra was acquired
at different temperatures from 2°C to 47°C (data not shown) to
investigate the temperature dependence of the chemical shifts of the
backbone NH protons.
Assignment of the NMR spectra
The spectra of di-P-(C36S)PLB36 (36-amino acid N-terminal
fragment of human phospholamban Cys-36
Ser mutated and phosphorylated at Ser-16 and Thr-17) display good chemical shift dispersion. The
complete spin-system and sequential assignments were obtained according
to Wüthrich (1986)
by use of COSY, total correlation spectroscopy, and NOESY spectra acquired at 17°C and 27°C.
Differences in the temperature dependence of the amido proton chemical
shifts were sufficient to unravel resonance overlap. Stereospecific
assignments for the methylene protons were deduced from coupling
constants JH
H
measured from the
COSY spectra and from intraresidual nuclear Overhauser enhancement
(NOE)-cross-peak intensities.
Structure generation and refinement
A series of NOESY spectra was acquired at 17°C with four
different mixing times (50, 80, 120, 170 ms). The integrated cross-peak intensities (I) were used in a NOESY-build-up analysis.
Distance restraints were extracted from the initial slope of a
second-order polynomial fitted to integrated cross-peak volumes of the
NOE-series with the initial condition
I(
m = 0) = 0. Some of the
intramethylene and sequential NOEs served for the calibration. When a
distance could not be extracted from the build-up curve, owing to a
partial (>10%) overlap, a poor signal-to-noise ratio or disturbances, it was only required that the distance was at most 6.0 Å. The upper
bounds were extended by 1.0 Å for each pseudo atom. The distances were
initially classified as short, medium, and long to provide restrains
for the generation of the first set of structures. The restraint data
were supplemented with distance restraints derived from the 200-ms
NOE-spectrum acquired at 17°C. During the refinement the distances
from the NOESY-build-up analysis were given a
40%/+10% uncertainty
and from the 200-ms NOE-spectrum a
50%/+20% uncertainty.
Coupling constants (J) were measured by the
J-doubling method (McIntyre and Freeman, 1992
) from the fine
structures of COSY cross-peaks. Dihedral angles
and
characterized by intermediate J values were not constrained,
but small and large JNH
and JH
H
were related to staggered
conformers (±30°) on the basis of Karplus functions and
intraresidual NOEs. The H-H distance and dihedral angle restraints were
calculated with the software FELIX (MSI). Finally, the data were
imported in the software InsightII (MSI) to create, evaluate and refine
a family of structures, and, eventually, to back calculate simulated
NOESY spectra for comparison.
Structures were generated by distance geometry (DGII) followed by
simulated annealing (force field cvff). A set of 50 structures was computed. The structures with least restraint violations were used
to back calculate NOE matrices. Based on the comparison of the
back-calculated and experimental NOE spectra it became possible to
unambiguously identify a few more NOEs and impose corresponding distance restraints. Also the
dihedral angles in the
-helical segments were constrained (±60°) provided that an H
-chemical shift departed from the corresponding random coil value by more than
0.2 ppm. A new set of structures was subsequently calculated. In
total there were 530 distance and 27 dihedral angle restraints excluding those that were defined more accurately by the covalent structure alone. These redundant NOE-derived restraints were consistent with the covalently imposed limits obtained from the sequential tetragonal bound smoothing, which indicated that the calibration of
distances was correct. The restraint violations of the final accepted
family of structures were below 0.1 Å. Finally, to consider the role
of Coulombic interaction between the phosphorous of Ser-16 and Thr-17
with Arg-9, Arg-13, and Arg-14 the final family of structures were
subjected to a minimization in the presence of charges and NMR-based
restraints. The distance dependent dielectric constant was given value
of 1.4 F × m
1.
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
Preparation of the sample
Solubility tests were performed to assess which conditions (TFE
concentration, temperature, pH values) were suitable for a stable
aqueous NMR sample containing millimolar concentrations of
di-P-(C36S)PLB36. Among some possible solutions, it was preferential to
prepare a 3-mM solution of the 36-amino acids fragment of
phosphorylated phospholamban in the solvent mixture
H2O/D2O/d3-TFE
(63:7:30) at pH 3.05 ± 0.05 and to study this sample at 27°C.
This choice was also dictated by the fact those conditions were the
same at which the unphosphorylated PLB1-36 was soluble, and it was
thus possible to compare the structures obtained for phosphorylated and
unphosphorylated PLB1-36 in the same solution. It should be pointed
out that the phosphate groups maintain one net charge at the pH value
selected for the experiment. In fact, for phosphoserine and
phosphothreonine peptides, the pKa1 of the
phosphoryl group lies below 2, whereas the pKa2
is at 5.9 (Hoffmann et al., 1994
). The presence of TFE, also needed for
the solubility, could be important also to mimic the transmembrane
environment of part of the peptide. A 31P-NMR
spectrum was acquired (Fig. 1) and shows
two well-resolved peaks that could be assigned to phosphoserine (+0.56
ppm) and phosphothreonine (
0.43 ppm).
|
Assignment
The complete spin-system and sequential assignments are
listed in Table 1. More than 600 NOEs
were assigned, and all of the 34 possible
intra-NH-C
H correlations were observed in the finger-print region. The secondary shift (
) of
CH (defined as
the difference between the chemical shift observed for di-P-(C36S)PLB36 in aqueous solution at pH 3.05 with 30% TFE and the random coil chemical shift for each residue) is shown in Fig.
2. Negative (upfield) 
values are
related to
-helical secondary structure (Wishart et al., 1992
). In
the same figures, for comparison, the secondary shift of
CH of the
nonphosphorylated PLB36, acquired at the same conditions, are shown
(Pollesello et al., 1999
). The region from Arg-9 to Ile-18 appears much
less structured in di-P-(C36S)PLB36 than in the unphosphorylated
peptide. Such data are in agreement with the results of Quirk et al.
(1996)
obtained for shorter PLB peptides in phosphorylated and
unphosphorylated form. The one-dimensional NMR spectra of 3 mM
di-P-(C36S)PLB36 in 63% H2O/7%
D2O/30% d3-TFE, pH
3.05 ± 0.05, were acquired at different temperatures, namely from
0°C to 40°C in 5°C steps (data not shown). The
temperature-dependent shift of a number of the backbone NH protons do
not follow the temperature-dependent shift of the water (
10
ppb/°C), thus indicating the presence of several H-bonds. When
compared with the same spectra acquired for the unphosphorylated PLB
(Pollesello et al., 1999
) it can be noticed that the overall dispersion
of the NH peaks in the fingerprint region (9 >
> 7 ppm)
is similar for di-P-(C36S)PLB36 and PLB36.
|
|
Structure of di-P-(C36S)PLB36
The structure of di-P-(C36S)PLB36 was determined from 530 distance
and 27 dihedral restraints excluding those that were defined more
accurately by the covalent structure alone (Table
2). Twenty-four structures of
di-P-(C36S)PLB36 deduced from NMR data with no violations >0.1 Å are
shown in Fig. 3 after
being superimposed on the C
of the residues 22-35. In all of the
structures, both the C-terminal fragment (from amino acids 22-35) and
the N terminus (from amino acids 2-12) are
-helices. When
superimposing the 24 NMR structures on the C-terminal helix, the
N-terminal helix appears dispersed in a cone with an opening angle of
~80°. To compare the structures of the phosphorylated and
nonphoaphorylated PLB peptides was convenient to compute the so called
"packing parameters" (defined for
-helix dimers by Chothia et
al. (1981)
for the two sets of structures and compare the average
values of the crossing angle
(defined as the torsion angle between
the axes of the two helices when projected on a contact plane) and the
distance of closest contact d in the two sets. According to
the definition, for
= 0° the two helices are perfectly
parallel and orthogonal for
= 90°. When the axes of the two
helices are on the same plane, d = 0. In the case of
di-P-(C36S)PLB36,
= 100 ± 35° and d = 7.9 ± 4.6 Å, when the average and standard deviation values were
calculated over 24 structures with no violations >0.1 Å. The values
of
and d for the unphosphorylated PLB36 were 80 ± 20° and 7.0 ± 4.0 Å, respectively, when calculated for the
family of 18 structures with no violations >0.2 Å shown in our
previous paper (Pollesello et al., 1999
). Therefore neither in the
nonphosphorylated nor in the phosphorylated PLB structures the two
-helices are closely packed. However, the standard deviation of the
value obtained for the phosphorylated peptide is larger than for
the unphosphorylated peptide, indicating even more loose packing.
|
|
We attribute the very loose packing of the phosphorylated peptide to
the phosphorylated amino acids that disrupt the N-terminal helix
adjacent to the turn connecting to the C-terminal helix (Fig. 2).
Whereas in the nonphosphorylated PLB the region from Arg-13 to Thr-17
is an
-helix and only the short region from Ile-18 to Pro-21 is a
less structured turn (Pollesello et al., 1999
).
It appears that the two helices are further apart from each other in the phosphorylated peptide than in the nonphosphorylated form. However, structural integrity in the phosphorylated region may still be present due to ionic bridges between the phosphate groups of the two phosphorylated amino acids (Ser-16 and Thr-17) and two arginines (Arg-13 and Arg-14).
When minimizing the structures in the presence of Coulumbic
interactions, we found favorable interactions between the side chain
groups. In the majority of the structures of the family, in fact, the
distance from the carbon CZ of Arg-13 to the phosphorus atom of Thr-17
is between 3.85 and 5.50 Å, and the distance from the carbon CZ of
Arg-14 to the phosphorus atom of Ser-16 is between 4.25 and 6.00 Å (Fig. 4 A). In a few
structures of the family, also Arg-25 comes close to the phosphate
group of Ser-16, whereas Arg-9 is never close to either phosphate
groups. A comparison of the structure of di-P-(C36S)PLB36 and PLB36 is
shown in Fig. 4 B, where two representative structures are
superimposed on the C
of the residues 22-35. It can be noticed that
the interaction between the phosphate groups and the arginine polar
heads in di-P-(C36S)PLB36 create a second bend (the first being located
on the proline residue) with the result that the distance between the
two
-helices in di-P-(C36S)PLB36 is bigger than in PLB36. The
structure shown in Fig. 4 is consistent with the structural data on the
direct effects of phosphorylation on the preferred backbone
conformation of peptides described by Tholey et al. (1999)
.
|
A molecular model of the transmembrane domain of phospholamban
was proposed, in which a symmetric homopentamer composed of a
left-handed coiled coil of
-helices (Simmerman et al., 1996
) is
stabilized by a leucine-isoleucine zipper. In a separate publication (Pollesello et al., 1999
), the structure PLB36 was resolved by NMR and
connected to the transmembrane pentamer model proposed previously. In
this way a model of the whole phospholamban in its pentameric form was
generated in which the inner side of the cytoplasmic domain of the
pentamer (where the helices face one another) was lined by polar
residues (Gln-23, Gln-26, and Asn-30), whereas the positively charged
Arg-25 and Lys-27 side chains were on the outer side.
Because the present data show that the phosphorylation of PLB36 occurs
without any modification of the structure in the fragment 21-36, which
remains as a well-characterized
-helix, it is possible to use the
same docking method described previously and build a model of the
phosphorylated PLB pentamer. Molecular modeling was performed to
evaluate if the interaction between the phosphate groups of one monomer
and the Arg-25 or Lys-27 of the neighbor monomers in the pentamer is
possible. The data (not shown) did not confirm this hypothesis because
in all the structures analyzed none of the phosphate groups on the N
terminus was close to any of the positively charged groups of the C
terminus of the neighbor monomers.
Indeed, a role of the phosphorylation in the stabilization of the PLB
pentamer structure was proposed by Cornea et al. (1997)
. The authors
performed electron paramagnetic resonance experiments on lipid
reconstituted recombinant PLB, showed a phosphorylation-dependent increase in the degree of oligomerization, but concluded that this
effect was due simply to a reduced electrostatic repulsion among the
phosphorylated PLB monomers. This explanation, not based on any
specific interdomain electrostatic interaction, is consistent with our data.
Recently, the structure of a point mutated (Cys-41
Phe) monomeric PLB
was resolved by NMR in a mixture of organic solvents (CHCl3/MeOH) (Lamberth et al., 2000
). The family of
structures shown in that paper was consistent with the data obtained
for PLB36 in water/TFE (Pollesello et al., 1999
). It would be of
interest to compare the structure of the di-phosphorylated PLB in the
different two solvent systems to understand if the structural changes
induced by the two phosphate groups are 1) independent of the
environment and 2) maintained also in the whole length PLB.
| |
FOOTNOTES |
|---|
Address reprint requests to Piero Pollesello, Orion Pharma, Cardiovascular Research, P.O. Box 65, FIN-02101 Espoo, Finland. Tel.: 358-50-429-4191; Fax: 358-10-429-2924; E-mail: piero.pollesello{at}orionpharma.com.
Submitted December 4, 2001, and accepted for publication March 27, 2002.
| |
REFERENCES |
|---|
|
|
|---|
-agonist stimulation.
Circ. Res.
75:401-409
Biophys J, July 2002, p. 484-490, Vol. 83, No. 1
© 2002 by the Biophysical Society 0006-3495/02/07/484/07 $2.00
This article has been cited by other articles:
![]() |
M. G. Paterlini and D. D. Thomas The {alpha}-Helical Propensity of the Cytoplasmic Domain of Phospholamban: A Molecular Dynamics Simulation of the Effect of Phosphorylation and Mutation Biophys. J., May 1, 2005; 88(5): 3243 - 3251. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Lindhout, A. Thiessen, D. Schieve, and B. D. Sykes High-yield expression of isotopically labeled peptides for use in NMR studies Protein Sci., August 1, 2003; 12(8): 1786 - 1791. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |